XTEK directors support expansion strategy with on-market purchases The company recently signed an agreement to exclusively distribute and support Virolens in Australia and New Zealand and late last year secured a $1 million contract for the next phase of the C4 EDGE Program for the Australian Army. Uwe Boettcher now holds a total of 5,740,408 shares in the company and Chris Fullerton holds 200,000. XTEK Ltd (ASX:XTE) directors have displayed confidence in the company’s growth strategy through on-market share purchases. Non-executive director and chairman Uwe Boettcher has today purchased 70,000 shares in a direct interest at $0.55 per share. In addition, non-executive director Chris Fullerton also made an on-market purchase today, acquiring 56,521 shares at $0.56 each in a direct interest.